G8 vaccine plan in danger of failure

Jul 07, 2006

A disagreement between the United States and France may prevent a proposed vaccine program from being approved by G8 leaders.

A senior official with knowledge of the discussions said the proposal, which would offer incentives to pharmaceutical companies that develop working vaccines, "is now in substantial danger of flopping even though there is an extraordinary level of support among some key stakeholders," The Wall Street Journal reported Friday.

Officials from the United States and France engaged in a heated debate at a G8 meeting last month over a French proposition for an international airline-ticket tax to benefit poor countries in need of aid. French officials said at the meeting they would not approve the vaccine plan unless the airline tax passed, but the Bush administration has refused to consider it, the senior official told the Journal.

Japan and Germany have also expressed reservations about the possible cost of the vaccine plan. "A number of other governments in the G8 don't want to pony up more money for something right now," said a senior U.S. Treasury official, the Journal reported.

Copyright 2006 by United Press International

Explore further: Time is muscle in acute heart failure

Related Stories

"Supershedders" role in spreading E. coli scrutinized

May 13, 2014

Though you can't tell just by looking at them, some of the cattle grazing in a pasture, or noshing high-energy rations in a feedlot pen, may be "supershedders"—meaning they shed high levels of pathogenic ...

Right, left, wrong: People reject science because ...

Oct 03, 2013

You'd be forgiven for thinking science is under attack. Climate science has been challenged by deniers and sceptics, vaccination rates are falling thanks to anti-vaccination movements, and GM crops are pillaged ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

4 hours ago

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

School scoliosis screening has sustained effectiveness

5 hours ago

(HealthDay)—School scoliosis screening can have sustained clinical effectiveness in identifying patients with adolescent idiopathic scoliosis, according to a study published in the May 1 issue of The Sp ...

AMA: avoiding distress in medical school

6 hours ago

(HealthDay)—Understanding the key drivers underlying medical students' distress can help address the issues and enhance student well-being, according to an article published by the American Medical Association.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.